Interestingly, familial AD patients have exhibited mutations in three of the five cysteine residues in presenilin-1, indicating the relevance of sensitive-cysteine redox deregulation in AD pathophysiology in early-onset cases [117,118] (Figure 1). Here, PSEN1 is linked to Alzheimer disease.